Prevention of influenza by the intranasal administration of cold-recombinant, live-attenuated influenza virus vaccine: importance of interferon-γ production and local IgA response
- 1 January 1995
- Vol. 13 (2) , 185-190
- https://doi.org/10.1016/0264-410x(95)93134-u
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Human Interferon Alpha and Gamma Production by Lymphocytes During the Generation of Influenza Virus-specific Cytotoxic T LymphocytesJournal of General Virology, 1986
- Reinfection with Influenza A (H2N2, H3N2, and H1N1) Viruses in Soldiers and Students in JapanThe Journal of Infectious Diseases, 1986
- ADVANTAGE OF LIVE ATTENUATED COLD-ADAPTED INFLUENZA A VIRUS OVER INACTIVATED VACCINE FOR A/WASHINGTON/80 (H3N2) WILD-TYPE VIRUS INFECTIONThe Lancet, 1984
- Cytotoxic T-Cell Immunity to InfluenzaNew England Journal of Medicine, 1983
- Evaluation of a Cold-Recombinant Influenza Virus Vaccine in FerretsThe Journal of Infectious Diseases, 1982
- Consideration of the Risk of Influenza in Children and Indications for ProphylaxisClinical Infectious Diseases, 1980
- Interferon production in children with respiratory syncytial, influenza, and parainfluenza virus infectionsThe Journal of Pediatrics, 1978
- The Recovery of Mice from Influenza Virus Infection: Adoptive Transfer of Immunity with Immune T LymphocytesScandinavian Journal of Immunology, 1978
- Pilot Studies on Recombinant Cold-Adapted Live Type A and B Influenza Virus VaccinesThe Journal of Infectious Diseases, 1977
- Production of Interferon in Volunteers Infected with Asian InfluenzaThe Journal of Infectious Diseases, 1970